A Study to evaulate the efficacy of Dadrughna Lepa in Fungal Dermatophytosis.
Not Applicable
- Conditions
- Health Condition 1: B354- Tinea corporis
- Registration Number
- CTRI/2023/05/052676
- Lead Sponsor
- Dr VISHNU S
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
SUBJECTS FALLING UNDER B36 OF ICD10 CLASSIFICATION,CLINICAL SIGNS AND SYMPTOMS OF DADRU KUSHTA AS DESCRIBED IN CLASSICAL TEXTS (PRESENCE OF UDGATA MANDALA WITH OR WITHOUT OTHER SYMPTOMS),SUBJECTS WILLING TO PARTICIPATE IN THE STUDY WITH WRITTEN INFORMED CONSENT WHICH IS CONVEYED IN THE LANGUAGE WHICH THE SUBJECT CAN UNDERSTAND
Exclusion Criteria
PREGNANT AND LACTATING WOMEN.
SUBJECTS HAVING ANY UNCONTROLLED SYSTEMIC ILLNESS WHICH CAN INTERFERE WITH THE COURSE OF DISESASE AND TREATMENT,
OTHER OVERLAPPING DERMATOLOGICAL DISEASES WILL BE EXCLUDED,
SUBJECTS UNDER ANTI-FUNGAL DRUGS WILL BE EXCLUDED.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in KASI scoreTimepoint: before intervention-0th day <br/ ><br>during intervention-10th day <br/ ><br>after intervention-21st day <br/ ><br>follow up-28th day
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI